Martin Edwards
Europe, England, United Kingdom'%3e%3cpath fill='%23012169' d='M0 0v30h60V0z'/%3e%3cpath stroke='%23fff' stroke-width='6' d='m0 0 60 30m0-30L0 30'/%3e%3cpath stroke='%23C8102E' stroke-width='4' d='m0 0 60 30m0-30L0 30' clip-path='url(%23b)'/%3e%3cpath stroke='%23fff' stroke-width='10' d='M30 0v30M0 15h60'/%3e%3cpath stroke='%23C8102E' stroke-width='6' d='M30 0v30M0 15h60'/%3e%3c/g%3e%3c/svg%3e)
Description
Dr. Edwards joined Novo A/S in 2003 working out of the UK. He is chairman of the Board of Directors of Vantia Therapeutics Ltd. and NeRRe Th...
Investor Profile
Martin Edwards has backed more than 1 startups, with 0 new investments in the last 12 months alone. The firm has led 0 rounds, about 0% of its total and boasts 1 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Post Ipo Equity rounds (top funding stages).
- Majority of deals are located in United Kingdom.
- Strong thematic focus on Biotechnology, Pharmaceutical, Therapeutics.
Stage Focus
- Post Ipo Equity (100%)
Country Focus
- United Kingdom (100%)
Industry Focus
- Biotechnology
- Pharmaceutical
- Therapeutics
FAQ
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.
Who does Martin Edwards frequently co-invest with?
Which angels does Martin Edwards often collaborate with?
What are some of recent deals done by Martin Edwards?
Find More Investors Like Martin Edwards
Discover similar investors in our database and build your perfect investor list.
Need help with your fundraising strategy?Read our fundraising guides
